Explore

NAMI Webinar Explores Metabolic Psychiatry and Ketogenic Therapy for Mental Illness

NAMI Webinar Explores Metabolic Psychiatry and Ketogenic Therapy for Mental Illness

The National Alliance on Mental Illness (NAMI) recently hosted an 'Ask the Expert' webinar focusing on metabolic psychiatry and the use of ketogenic therapy for psychiatric conditions. The webinar featured Hannah Warren, Communications and Advocacy Manager for Metabolic Mind, who shared her personal experience of achieving remission from bipolar I disorder using metabolic therapies, and Dr. Carlo Longhitano, a psychiatrist involved in a randomized controlled trial on ketogenic metabolic therapy. The discussion highlighted the historical context of dietary interventions for mental health, dating back to ancient times and early 20th-century medical practices for epilepsy. Both speakers emphasized that ketogenic therapy, while powerful, should be undertaken with medical supervision and can serve as an adjunctive treatment alongside traditional medications. The webinar also addressed practical aspects, such as the affordability of a ketogenic diet and the ongoing research to establish definitive recommendation...

Research Links Stable Circadian Rhythms to Improved Blood Glucose Control in Type 2 Diabetes Patients

Research Links Stable Circadian Rhythms to Improved Blood Glucose Control in Type 2 Diabetes Patients

A research team, including Dr. Lee Da young and Dr. Nan Hee Kim from Ansan Hospital, has found a significant correlation between stable circadian rhythms and better blood glucose management in individuals with type 2 diabetes. The study, published in the journal Metabolism, involved 122 patients with type 2 diabetes receiving insulin treatment at Ansan Hospital between 2021 and 2024. Participants wore continuous glucose monitors (CGM) and wearable activity monitors for 10 days to collect data on blood glucose fluctuations, sleep patterns, physical activity levels, and heart rates. The findings revealed that 46.3% of patients with the most stable circadian rhythms achieved their blood glucose management goals, a rate approximately 2.3 times higher than the 20.0% observed in patients with the least stable rhythms. This association remained significant even after adjusting for factors such as age, BMI, and HbA1c. The research also indicated that afternoon activity had the strongest correlation with blood gluc...

Eggs Offer Diverse Culinary Uses and Significant Nutritional Benefits

Eggs Offer Diverse Culinary Uses and Significant Nutritional Benefits

Eggs are highlighted for their versatility in various dishes, including pasta, stir-fries, salads, sandwiches, and wraps, serving as a convenient protein source. Beyond their culinary applications, eggs are recognized for their rich nutritional profile. They contain essential vitamins, selenium, Vitamin D, and Vitamin B12. Notably, eggs are a significant source of choline, a nutrient vital for normal brain and nervous system function, with a large boiled egg providing approximately 147mg of choline. Additionally, eggs contain lutein and zeaxanthin, carotenoids known for their association with eye health. The perception that dietary cholesterol from eggs directly elevates blood cholesterol levels has been largely disproven, as blood cholesterol is more significantly influenced by saturated fat intake and other dietary and genetic factors. Eggs are also noted for being a cost-effective, high-quality protein source with a relatively long shelf life.

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

Study Identifies Beta-Synuclein as Early Blood Biomarker for Alzheimer's in Down Syndrome Patients

A new study, published in Alzheimer's & Dementia, has identified beta-synuclein as a promising early blood-based biomarker for Alzheimer's disease in individuals with Down syndrome. Researchers from Sant Pau Research Institute (IR Sant Pau), in collaboration with Martin Luther University and the German Center for Neurodegenerative Diseases, found that beta-synuclein levels begin to rise in people with Down syndrome from their third decade of life, approximately 21 years before the average age of prodromal Alzheimer's diagnosis in the studied cohort. Beta-synuclein, a protein primarily located at presynaptic terminals, provides insights into synaptic dysfunction and degeneration, which are considered early events in Alzheimer's. The study analyzed 131 individuals, including 88 adults with Down syndrome at various disease stages and 43 cognitively healthy controls. Results showed beta-synuclein levels were 1.83 times higher in asymptomatic Down syndrome individuals compared to controls, increasing with disea...

Gut Inflammation Linked to Food Sensitivities in IBD Patients Due to Altered Microbiota

Gut Inflammation Linked to Food Sensitivities in IBD Patients Due to Altered Microbiota

A new study published in Gastroenterology suggests that gut inflammation can alter the way gut bacteria break down food, potentially triggering immune reactions to previously tolerated foods. This mechanism may explain why many individuals with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, experience adverse reactions to foods like dairy and gluten, even when their IBD is in remission. The research indicates that inflammation depletes specific gut bacteria responsible for processing certain food triggers. This disruption in microbial digestive capacity can lead to increased sensitization and heightened immune responses when these foods are consumed. The study involved both mouse models of colitis and an observational study of 148 adults, including IBD patients and controls. It found that IBD patients who reported food intolerances had a reduced ability to break down common trigger foods and lower levels of the associated bacteria. The findings highlight the gut microbi...

FDA Maintains Hold on Newron's Schizophrenia Drug Trial Following Multiple Patient Deaths

FDA Maintains Hold on Newron's Schizophrenia Drug Trial Following Multiple Patient Deaths

The U.S. Food and Drug Administration (FDA) is maintaining a hold on Newron Pharmaceuticals' Phase 3 ENIGMA-TRS 2 trial for evenamide, an investigational schizophrenia drug. This decision follows the revelation of four patient deaths among those receiving evenamide across all clinical studies, with a fifth death occurring in the placebo group. The FDA initially placed a hold on the trial in April after one patient death, which Newron had deemed unrelated to the drug. The agency's concern stems from evenamide's mechanism of action as a selective voltage-gated sodium channel blocker, a class of drugs that can potentially cause irregular heartbeats and serious cardiovascular events or seizures. Newron states that three of the four deaths in the investigational group are considered unrelated to the treatment, while one death's cause remains undetermined, making it 'possibly related.' The company is currently reviewing the FDA's feedback and all safety data, including over 10,000 ECGs from approximately 700 pat...

Sugar-Rich Diets Exacerbate Antibiotic-Induced Gut Microbiome Disruption in Transplant Patients

Sugar-Rich Diets Exacerbate Antibiotic-Induced Gut Microbiome Disruption in Transplant Patients

A recent Nature study, tracking over 9,400 meals from hematopoietic cell transplantation (HCT) patients, revealed a link between sugar-rich diets and increased gut microbiome disruption when combined with antibiotic exposure. Researchers found that higher sugar intake during broad-spectrum antibiotic treatment was associated with a greater reduction in gut microbial alpha-diversity. This effect was particularly pronounced for every additional 100g of sweets consumed, leading to an estimated 24% further reduction in diversity. Mouse model experiments corroborated these findings, showing that sucrose supplementation after antibiotics increased the expansion of *Enterococcus faecium*, a key antibiotic-resistant pathogen, by 16.3-fold on day 3 and 33.4-fold on day 6 compared to antibiotic-treated mice without additional sugar. The study suggests that dietary sugars may favor the growth of opportunistic bacteria, weaken the protective effects of competing gut microbes, or alter host intestinal responses, thereb...

GLP-1s Show Potential to Slow Biological Aging, Study Suggests

GLP-1s Show Potential to Slow Biological Aging, Study Suggests

GLP-1s Show Potential to Slow Biological Aging, Study Suggests

University of Florida Study Addresses Workplace Strain in Agricultural Sector

University of Florida Study Addresses Workplace Strain in Agricultural Sector

A University of Florida-led study, conducted by scientists at the Southeastern Coastal Center for Agricultural Health and Safety (SCCHS), is investigating workplace strain in the agricultural sector, particularly among nursery and landscape workers. The research highlights the significant physical toll on these workers, who often endure long hours of lifting, carrying, digging, and maintaining awkward positions, leading to chronic pain and potential long-term health complications. The study found that working through pain can contribute to injuries, burnout, lost productivity, and difficulties in retaining experienced employees. Researchers developed short videos covering medication risks, pain management alternatives, and task modification strategies to reduce physical strain. Preliminary findings indicate improvements in task difficulty and pain among participants. A key finding emphasizes the crucial role of supervisors in promoting a workplace culture that encourages employees to report pain and guides...

VCU-Led Study Links Fatty Liver Disease to Increased Bone Fracture Risk

VCU-Led Study Links Fatty Liver Disease to Increased Bone Fracture Risk

A study led by Virginia Commonwealth University (VCU) suggests that individuals diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver disease, face a higher risk of bone fractures. This increased risk is observed independently of other metabolic conditions like obesity. The research, published in Nature’s Communications Biology journal, analyzed medical records from over 3.8 million people with metabolic conditions. It found that those with MASLD had a 23% higher risk of fractures, with the increase being most significant in adults over 40. After age 50, MASLD patients also showed a higher risk of fractures due to weakened bones. Animal models in the study indicated that MASLD might contribute to thinner, weaker outer bones and a reduction in osteoblasts, the cells responsible for building new bone.

Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health

Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health

Post-Menopausal Women Advised to Adopt Weight-Bearing and Strength Routines for Bone Health

NHLBI Mandates Justification for Animal Use in Research Grant Applications by 2027

NHLBI Mandates Justification for Animal Use in Research Grant Applications by 2027

The National Heart, Lung, and Blood Institute (NHLBI) will require all grant applications submitted from January 2027 onwards to include an explicit justification for the use of animal models. This justification, to be placed in the application's Abstract section, must explain why animal models are necessary and why alternative methods are inferior. This new requirement aligns with the National Institutes of Health's (NIH) broader initiative to accelerate efforts in replacing, reducing, and refining animal use in research through New Approach Methodologies (NAMs). The NIH's Unified Strategy, announced earlier this year, aims to prioritize human-based research, particularly for chronic health issues affecting Americans, while reducing reliance on animal models. The NHLBI supports this strategy and encourages the development and use of NAMs in heart, lung, blood, and sleep research, citing examples like 3D 'valve-like assembloids' from human stem cells and lung iPSCs resources.